Sharifi MN, Anandan A, Grogan P, O'Regan RM, et al. Therapy after cyclin-dependent kinase inhibition in metastatic hormone receptor-positive breast cancer: Resistance mechanisms and novel treatment strategies. Cancer 2020 May 19. doi: 10.1002/cncr.32931.
PMID: 32426848